Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | Tetrazocine |
|---|---|
| Location: | Melbourne, VIC, Australia |
| Users: | 12 |
| Nodes: | 8 (0 / 8) |
| Uptime: | 30:22:37 |
| Calls: | 220 |
| Files: | 21,513 |
| Messages: | 84,565 |